KCNA inhibitors are a class of chemical compounds that specifically target and inhibit the function of KCNA channels, which are voltage-gated potassium (Kv) channels. These channels are crucial for maintaining and regulating the electrical activity of cells, particularly in excitable tissues like neurons and muscles. KCNA channels, also known as Kv1 channels, are part of a large family of potassium channels that open in response to changes in membrane potential, allowing potassium ions to flow out of the cell. This flow of potassium helps repolarize the cell membrane following an action potential, thereby restoring the resting membrane potential and ensuring proper cellular excitability. Inhibiting KCNA channels disrupts this process, providing insights into how potassium flux influences cellular excitability, action potential duration, and signal propagation.
The mechanism of KCNA inhibitors generally involves binding to key regions of the Kv1 channel, such as the pore domain or voltage-sensing domain, to block the flow of potassium ions. Structurally, these inhibitors can act by occluding the potassium-conducting pore or by altering the channel's ability to respond to changes in membrane voltage, thus preventing channel opening. Some KCNA inhibitors may be selective for specific isoforms of the Kv1 family, enabling precise control over individual channel subtypes in various research contexts. By studying KCNA inhibitors, researchers gain valuable knowledge about the regulation of ion channel activity, the role of potassium currents in controlling cellular electrical properties, and the broader effects of potassium channel inhibition on physiological processes like neuronal firing, muscle contraction, and cellular signaling. These inhibitors are essential tools for exploring the function of Kv channels in both basic and applied research related to cellular electrophysiology and ion transport.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Quinidine | 56-54-2 | sc-212614 | 10 g | $102.00 | 3 | |
Quinidine is a voltage-gated potassium channel blocker that inhibits various potassium channels including KVβ.3. It stabilizes the membrane potential, reducing the excitability of cardiac tissues and thus indirectly affecting KVβ.3's regulatory role in cardiac rhythm. | ||||||
Amiodarone | 1951-25-3 | sc-480089 | 5 g | $312.00 | ||
Amiodarone acts on several targets including potassium channels, leading to prolonged phase 3 of the cardiac action potential. Its broad spectrum activity includes modulation of KVβ.3 channels, impacting the electrical conductivity and arrhythmic potential of the heart. | ||||||
4-Aminopyridine | 504-24-5 | sc-202421 sc-202421B sc-202421A | 25 g 1 kg 100 g | $37.00 $1132.00 $120.00 | 3 | |
4-Aminopyridine is known for blocking voltage-gated potassium channels, enhancing neurotransmitter release. This blocker specifically inhibits KVβ.3 among other subunits, which may lead to changes in nerve conduction and muscle control. | ||||||